Latest Breaking News On - Steven shallcross - Page 1 : comparemela.com

Theriva: FDA Grants Fast Track Designation To Lead Clinical Candidate VCN-01

Theriva Biologics (TOVX) announced the FDA has granted Fast Track Designation to lead clinical candidate VCN-01 in combination with gemcitabine and nab-paclitaxel to improve progression-free survival and overall survival in patients with metastatic pancreatic adenocarcinoma.

Theriva biologicsSteven shallcrossMore such health newsFast track designation

Theriva Biologics Announces Positive Data From Phase 1 Trial Of VCN-01 In Intraocular Retinoblastoma

Theriva Biologics Announces Positive Data From Phase 1 Trial Of VCN-01 In Intraocular Retinoblastoma
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Steven shallcrossTheriva biologicsInstaforex companyTheriva biologics incTheriva biologic

Theriva Biologics, Inc (NYSE:TOVX) Q4 2023 Earnings Call Transcript

Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc.

United statesSteven shallcrossTheriva biologicsManel cascalloChris calabreseVince wacherJames molloyAlliance global partnersWashington universityProduct development of theriva biologicsUniversity of pennsylvaniaAlbumin shield technologyTheriva biologics incExchange commissionSociety for immunotherapy of cancer annual meetingData monitoring committee

Theriva Biologics, Inc (ASE:TOVX) Q2 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, good morning, and welcome to the Theriva Biologics, Inc. 2023 Second Quarter Earnings Conference Call.

United statesComunidad autonoma de catalunaJames molloyChris calabreseManel cascallSteven shallcrossRamon alemanyVince wacherTheriva biologicsWashington universityVirotherapy groupAlliance global partnersProduct development of theriva biologicsCatalan institute of oncologyTheriva biologics incUniversity of leeds

Theriva Biologics reveals positive VCN-01 study results

Theriva Biologics reveals positive VCN-01 study results
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Steven shallcrossTheriva biologicsDrug administrationEuropean medicines agency